Articles dans des revues avec comité de lecture (396)
  1. 301. Awada, A., Hendlisz, A., & Piccart-Gebhart, M. (2006). Efficacité et effets secondaires des thérapies biologiques ciblées. Oncologie, 8(10), 883-885. doi:10.1007/s10269-006-0565-1
  2. 302. Kasper, B., Lossignol, D., Gil, T., Flamen, P., De Saint Aubain, N., & Awada, A. (2006). Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalp. Anti-cancer drugs, 17(10), 1223-1225. doi:10.1097/01.cad.0000231486.94191.65
  3. 303. Zhang, S., Zannikos, P., Awada, A., Piccart-Gebhart, M., Dirix, L. Y., Fumoleau, P., Verhaeghe, T., Francois, M., & De Porre, P. (2006). Pharmacokinetics of tipifarnib after oral and intravenous administration in subjects with advanced cancer. Journal of clinical pharmacology, 46(10), 1116-1127. doi:10.1177/0091270006291034
  4. 304. Ismael, G., de Azambuja, E., & Awada, A. (2006). Molecular profiling of a tumor of unknown origin. The New England journal of medicine, 355(10), 1071-1072. doi:10.1056/NEJMc061533
  5. 305. de Castro, G., & Awada, A. (2006). Side effects of anti-cancer molecular-targeted therapies (not monoclonal antibodies). Current opinion in oncology, 18(4), 307-315. doi:10.1097/01.cco.0000228733.55132.ea
  6. 306. Dumez, H., Awada, A., Piccart-Gebhart, M., Assadourian, S., Semiond, D., Guetens, G., De Boeck, G., Maes, R. A. A., de Bruijn, E. A., & van Oosterom, A. (2006). A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumours. Annals of oncology, 17(7), 1158-1165. doi:10.1093/annonc/mdl071
  7. 307. de Castro, G., Puglisi, F., de Azambuja, E., El Saghir, N. S., & Awada, A. (2006). Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm). Critical reviews in oncology/hematology, 59(1), 40-50. doi:10.1016/j.critrevonc.2006.02.007
  8. 308. Bourhis, J., Rivera, F., Mesia, R., Awada, A., Geoffrois, L., Borel, C., Humblet, Y., Lopez-Pousa, J. J., Hitt, R., Vega Villegas, M. E., Duck, L., Rosine, D., Amellal, N., Schueler, A., & Harstrick, A. (2006). Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Journal of clinical oncology, 24(18), 2866-2872. doi:10.1200/JCO.2005.04.3547
  9. 309. de Azambuja, E., Piccart-Gebhart, M., & Awada, A. (2006). Long-term survival in pituitary metastasis from breast cancer. Breast, 15(3), 446-447. doi:10.1016/j.breast.2005.06.007
  10. 310. Piccart-Gebhart, M., & Awada, A. (2006). Targeted therapies for solid tumors: is the dream becoming a reality? Targeted Oncology, 1(3). doi:10.1007/s11523-006-0020-7
  11. 311. Awada, A., & de Castro, G. (2006). Management of advanced head and neck squamous cell carcinoma in elderly patients. Current opinion in oncology, 18(3), 225-227. doi:10.1097/01.cco.0000219249.07418.4c
  12. 312. Lalami, Y., Vereecken, P., Dequanter, D., Lothaire, P., & Awada, A. (2006). Salivary gland carcinomas, paranasal sinus cancers and melanoma of the head and neck: an update about rare but challenging tumors. Current opinion in oncology, 18(3), 258-265. doi:10.1097/01.cco.0000219255.30220.90
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 39 Suivant >>